| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | 0.28 | 0.0001 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | 0.15 | 0.006 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.69 | 0.006 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.008 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.26 | 0.01 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.069 | 0.03 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | -0.066 | 0.03 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.03 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.074 | 0.03 |